1269232-95-2
C6H4BrClFN
224.46
1.809±0.06
Anticancer
Encorafenib
BRAF
Availability: | |
---|---|
DESCRIPTION
Encorafenib, a potent BRAF inhibitor, has demonstrated remarkable efficacy in treating patients with advanced melanoma harboring BRAF mutations. Our meticulously crafted intermediates ensure a seamless manufacturing process, enabling the timely production and supply of this life-saving medication. Join forces with us to revolutionize cancer care, providing patients with renewed hope and improved outcomes. Together, let's pave the way for a brighter future with Encorafenib.
content is empty!